Victoria K Pepper1,2, Ekene A Onwuka1,3, Cameron A Best1, Nakesha King1,3, Eric Heuer1, Jed Johnson4, Christopher K Breuer1,2,3, Jonathan M Grischkan5, Tendy Chiang1,5. 1. Tissue Engineering Program, the Research Institute at Nationwide Children's Hospital, Columbus, Ohio, U.S.A. 2. Department of Pediatric Surgery, Nationwide Children's Hospital, Columbus, Ohio, U.S.A. 3. Department of General Surgery, the Ohio State University Wexner Medical Center, Columbus, Ohio, U.S.A. 4. Nanofibers Solutions, Inc, Columbus, Ohio, U.S.A. 5. Department of Pediatric Otolaryngology, Nationwide Children's Hospital, Columbus, Ohio, U.S.A.
Abstract
OBJECTIVE: To evaluate the safety and efficacy of bronchoscopic interventions in the management of tissue-engineered tracheal graft (TETG) stenosis. STUDY DESIGN: Animal research study. METHODS: TETGs were constructed with seeded autologous bone marrow-derived mononuclear cells on a bioartificial graft. Eight sheep underwent tracheal resection and orthotopic implantation of this construct. Animals were monitored by bronchoscopy and fluoroscopy at 3 weeks, 6 weeks, 3 months, and 4 months. Bronchoscopic interventions, including dilation and stenting, were performed to manage graft stenosis. Postdilation measurements were obtained endoscopically and fluoroscopically. RESULTS: Seven dilations were performed in six animals. At the point of maximal stenosis, the lumen measured 44.6 ± 8.4 mm2 predilation and 50.7 ± 14.1 postdilation by bronchoscopy (P = 0.3517). By fluoroscopic imaging, the airway was 55.9 ± 12.9 mm2 predilation and 65.9 ± 22.4 mm2 postdilation (P = 0.1303). Stents were placed 17 times in six animals. Pre- and poststenting lumen sizes were 62.8 ± 38.8 mm2 and 80.1 ± 54.5 mm2 by bronchoscopy (P = 0.6169) and 77.1 ± 38.9 mm2 and 104 ± 60.7 mm2 by fluoroscopy (P = 0.0825). Mortality after intervention was 67% with dilation and 0% with stenting (P = 0.0004). The average days between bronchoscopy were 8 ± 2 for the dilation group and 26 ± 17 in the stenting group (P = 0.05). One hundred percent of dilations and 29% of stent placements required urgent follow-up bronchoscopy (P = 0.05). CONCLUSION: Dilation has limited efficacy for managing TETG stenosis, whereas stenting has a more lasting clinical effect. LEVEL OF EVIDENCE: NA. Laryngoscope, 127:2219-2224, 2017.
OBJECTIVE: To evaluate the safety and efficacy of bronchoscopic interventions in the management of tissue-engineered tracheal graft (TETG) stenosis. STUDY DESIGN: Animal research study. METHODS:TETGs were constructed with seeded autologous bone marrow-derived mononuclear cells on a bioartificial graft. Eight sheep underwent tracheal resection and orthotopic implantation of this construct. Animals were monitored by bronchoscopy and fluoroscopy at 3 weeks, 6 weeks, 3 months, and 4 months. Bronchoscopic interventions, including dilation and stenting, were performed to manage graft stenosis. Postdilation measurements were obtained endoscopically and fluoroscopically. RESULTS: Seven dilations were performed in six animals. At the point of maximal stenosis, the lumen measured 44.6 ± 8.4 mm2 predilation and 50.7 ± 14.1 postdilation by bronchoscopy (P = 0.3517). By fluoroscopic imaging, the airway was 55.9 ± 12.9 mm2 predilation and 65.9 ± 22.4 mm2 postdilation (P = 0.1303). Stents were placed 17 times in six animals. Pre- and poststenting lumen sizes were 62.8 ± 38.8 mm2 and 80.1 ± 54.5 mm2 by bronchoscopy (P = 0.6169) and 77.1 ± 38.9 mm2 and 104 ± 60.7 mm2 by fluoroscopy (P = 0.0825). Mortality after intervention was 67% with dilation and 0% with stenting (P = 0.0004). The average days between bronchoscopy were 8 ± 2 for the dilation group and 26 ± 17 in the stenting group (P = 0.05). One hundred percent of dilations and 29% of stent placements required urgent follow-up bronchoscopy (P = 0.05). CONCLUSION: Dilation has limited efficacy for managing TETGstenosis, whereas stenting has a more lasting clinical effect. LEVEL OF EVIDENCE: NA. Laryngoscope, 127:2219-2224, 2017.
Authors: Hirotsugu Kurobe; Mark W Maxfield; Yuji Naito; Muriel Cleary; Mitchel R Stacy; Daniel Solomon; Kevin A Rocco; Shuhei Tara; Avione Y Lee; Albert J Sinusas; Edward L Snyder; Toshiharu Shinoka; Christopher K Breuer Journal: Tissue Eng Part C Methods Date: 2015-01 Impact factor: 3.056
Authors: Amy S Whigham; Rebecca Howell; Sukgi Choi; Maria Peña; George Zalzal; Diego Preciado Journal: Ann Otol Rhinol Laryngol Date: 2012-07 Impact factor: 1.547
Authors: N J Hamilton; M Kanani; D J Roebuck; R J Hewitt; R Cetto; E J Culme-Seymour; E Toll; A J Bates; A P Comerford; C A McLaren; C R Butler; C Crowley; D McIntyre; N J Sebire; S M Janes; C O'Callaghan; C Mason; P De Coppi; M W Lowdell; M J Elliott; M A Birchall Journal: Am J Transplant Date: 2015-06-02 Impact factor: 8.086
Authors: Martin J Elliott; Paolo De Coppi; Simone Speggiorin; Derek Roebuck; Colin R Butler; Edward Samuel; Claire Crowley; Clare McLaren; Anja Fierens; David Vondrys; Lesley Cochrane; Christopher Jephson; Samuel Janes; Nicholas J Beaumont; Tristan Cogan; Augustinus Bader; Alexander M Seifalian; J Justin Hsuan; Mark W Lowdell; Martin A Birchall Journal: Lancet Date: 2012-07-26 Impact factor: 79.321
Authors: Christian R Francom; Cameron A Best; Ryan G Eaton; Victoria Pepper; Amanda J Onwuka; Christopher K Breuer; Meredith N Merz Lind; Jonathan M Grischkan; Tendy Chiang Journal: Int J Pediatr Otorhinolaryngol Date: 2018-10-11 Impact factor: 1.675
Authors: Victoria Pepper; Cameron A Best; Kaila Buckley; Cynthia Schwartz; Ekene Onwuka; Nakesha King; Audrey White; Sayali Dharmadhikari; Susan D Reynolds; Jed Johnson; Jonathan Grischkan; Christopher K Breuer; Tendy Chiang Journal: Otolaryngol Head Neck Surg Date: 2019-04-30 Impact factor: 3.497
Authors: Elizabeth F Maughan; Robert E Hynds; Toby J Proctor; Sam M Janes; Martin Elliott; Martin A Birchall; Mark W Lowdell; Paolo De Coppi Journal: Curr Stem Cell Rep Date: 2017-10-26
Authors: Cynthia M Schwartz; Jacob Stack; Cynthia L Hill; Scott W Lallier; Tendy Chiang; Jed Johnson; Susan D Reynolds Journal: Laryngoscope Investig Otolaryngol Date: 2019-07-16